Literature DB >> 9813402

Delayed-onset ipsilateral sensory symptoms in patients with central poststroke pain.

J S Kim1.   

Abstract

Sensory symptoms almost always develop on the side contralateral to the cerebral lesion. Delayed occurrence of ipsilateral sensory symptoms after stroke has not been recognized. I describe 6 patients with unilateral stroke who initially developed painful sensory symptoms on the side contralateral to the lesion. The patients' central poststroke pain progressively worsened for a certain period of time when sensory symptoms also occurred on the side ipsilateral to the lesion. The delayed-onset ipsilateral sensory symptom was mild, unaccompanied by objective sensory deficits and developed at the body parts mirroring the site of the most severe central poststroke pain. Possible pathogenic mechanisms for this delayed-onset ipsilateral sensory symptom are discussed.

Entities:  

Mesh:

Year:  1998        PMID: 9813402     DOI: 10.1159/000007980

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  4 in total

1.  Quantitative and Fiber-Selective Evaluation for Central Poststroke Pain.

Authors:  Jian-Min Chen; Qing-Fa Chen; Zhi-Yong Wang; Guo-Xin Ni
Journal:  Neural Plast       Date:  2022-06-06       Impact factor: 3.144

2.  Late-onset hypersensitivity after a lesion in the ventral posterolateral nucleus of the thalamus: A macaque model of central post-stroke pain.

Authors:  Kazuaki Nagasaka; Ichiro Takashima; Keiji Matsuda; Noriyuki Higo
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

3.  Lysophosphatidic acid LPA1 and LPA3 receptors play roles in the maintenance of late tissue plasminogen activator-induced central poststroke pain in mice.

Authors:  Hiroshi Ueda; Hiroyuki Neyama; Keita Sasaki; Chiho Miyama; Ryusei Iwamoto
Journal:  Neurobiol Pain       Date:  2018-07-20

4.  Bilateral central pain sensitization in rats following a unilateral thalamic lesion may be treated with high doses of ketamine.

Authors:  Aude Castel; Pierre Hélie; Francis Beaudry; Pascal Vachon
Journal:  BMC Vet Res       Date:  2013-03-27       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.